The Testes: Disorders of Sexual Differentiation and Puberty in the Male

Pediatric Endocrinology

Volumn , Issue , 2008, Pages 662-685

  Hughes, Ieuan A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84870382121     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-141604090-3.50021-1     Document Type: Chapter

References (237)

1. Brennan J, Capel B One tissue, two fates: Molecular genetic events that underlie testis versus ovary development. Nat Rev Genet 2004, 5:509-521.
2. Park SY, Jameson JL Transcriptional regulation of gonadal development and differentiation. Endocrinol 2005, 146:1035-1042.
3. Wilhelm D, Koopman P The makings of maleness: Towards an integrated view of male sexual development. Nat Rev Genet 2006, 7:620-632.
4. Achermann JC, Hughes IA Disorders of sex differentiation. Williams' textbook of endocrinology 2007, 783-848. WB Saunders, Philadelphia. Eleventh edition. P.R. Larsen, H.M. Kronenberg, S. Melmed, K.S. Polonsky (Eds.).
5. Koziell A, Charmandari E, Hindmarsh PC, Rees L, Scambler P, Brook CG Frasier syndrome, part of the Denys-Drash continuum or simply a WT1 gene associated disorder of intersex and nephropathy?. Clin Endocrinol 2000, 52:519-524.
6. Ozisik G, Achermann JC, Meeks JJ, Jameson JL SF1 in the development of the adrenal gland and gonads. Horm Res 2003, 59(1):94-98.
7. Sullivan JG, Gohel M, Kinder RB Ectopic adrenocortical tissue found at groin exploration in children: Incidence in relation to diagnosis, age and sex. BJU Int 2005, 95:407-410.
8. Claahsen-van der Grinten HL, Otten BJ, Sweep FC, et al. Testicular tumors in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency show functional features of adrenocortical tissue. J Clin Endocrinol Metab 2007, 92:3674-3680.
9. Josso N, Clemente N Transduction pathway of anti-Müllerian hormone, a sex-specific member of the TGF-beta family. Trends Endocrinol Metab 2003, 14:91-97.
10. Hannema SE, Hughes IA Regulation of Wolffian duct development. Horm Res 2007, 67:142-151.
11. Wilson JD, Griffin JE, Russell DW Steroid 5α-reductase 2 deficiency. Endocr Rev 1993, 14:577-593.
12. Hutson JM, Hasthorpe S Testicular descent and cryptorchidism: The state of the art in 2004. J Pediatr Surg 2004, 40:297-302.
13. Zimmermann S, Steding G, Emmen JMA, et al. Targeted disruption of the Insl3 gene causes bilateral cryptorchidism. Mol Endocrinol 1999, 13:681-691.
14. Boucekkine C, Toublanc JE, Abbas N, et al. Clinical and anatomical spectrum in XX sex reversed patients: Relationship to the presence of Y specific DNA-sequences. Clin Endocrinol 1994, 40:733-742.
15. Koopman P, Gubbay J, Vivian N, Goodfellow P, Lovell-Badge R Male development of chromosomally female mice transgenic for Sry. Nature 1991, 351:117-121.
16. McElreavey K, Vilain E, Abbas N, Herskowitz I, Fellous M A regulatory cascade hypothesis for mammalian sex determination: SRY represses a negative regulator of male development. Proc Natl Acad Sci USA 1993, 90:3368-3372.
17. O'Shaughnessy PJ, Baker PJ, Johnston H The foetal Leydig cell: Differentiation, function and regulation. Int J Androl 2006, 29:90-95.
18. Auchus RJ The backdoor pathway to dihydrotestosterone. Trends Endocrinol Metab 2004, 15:432-438.
19. Hughes IA, Deeb A Androgen resistance. Best Pract Res Clin Endocrinol Metab 2006, 20:577-598.
20. Lonard DM, O'Malley BW Nuclear receptor coregulators: Judges, juries, and executioners of cellular regulation. Mol Cell 2007, 27:691-700.
21. Hughes IA, Houk C, Ahmed SF, Lee PA Consensus statement on management of intersex disorders. Arch Dis Child 2006, 91:554-563.
22. Houk CP, Hughes IA, Ahmed SF, Lee PA, for the Writing Committee for the International Consensus Conference Participants Summary of consensus statement on intersex disorders and their management. Pediatrics 2006, 118:753-757.
23. Bojesen A, Juul S, Gravholt CH Prenatal and postnatal prevalence of Klinefelter syndrome: A national registry study. J Clin Endocrinol Metab 2003, 88:622-626.
24. Lee YS, Cheng AW, Ahmed SF, Shaw NJ, Hughes IA Genital anomalies in Klinefelter's syndrome. Horm Res 2007, 68:150-155.
25. Aksglaede L, Wikström AM, Rajpert-De Meyts E, Dunkel L, Skakkebaek NE, et al. Natural history of seminiferous tubule degeneration in Klinefelter syndrome. Hum Reprod Update 2006, 12:39-48.
26. Wikström AM, Dunkel L, Wickman S, Norjavaara E, Ankarberg-Lindgren C, Raivio T Are adolescent boys with Klinefelter syndrome androgen deficient?: A longitudinal study of Finnish 47,XXY boys. Pediatr Res 2006, 59:854-859.
27. Schiff JD, Palermo GD, Veeck LL, Goldstein M, Rosenwaks Z, Schlegel PN Success of testicular sperm extraction (corrected) and intracytoplasmic sperm injection in men with Klinefelter syndrome. J Clin Endocrinol Metab 2005, 90:6263-6267.
28. de la Chapelle A The etiology of maleness in XX men. Hum Genet 1981, 58:105-116.
29. Vorona E, Zitzmann M, Gromoll J, Schüring AN, Nieschlag E Clinical, endocrinological, and epigenetic features of the 46,XX male syndrome, compared with 47,XXY Klinefelter patients. J Clin Endocrinol Metab 2007, 92:3458-3465.
30. Abusheikha N, Lass A, Brinsden P XX males without SRY gene and with infertility. Hum Reprod 2001, 16:717-718.
31. Rajender S, Rajani V, Gupta NJ, Chakravarty B, Singh L, Thangaraj K SRY-negative 46,XX male with normal genitals, complete masculinisation and infertility. Mol Hum Reprod 2006, 12:341-346.
32. Hoei-Hansen CE, Holm M, Rajpert-De Meyts E, Skakkebaek NE Histological evidence of testicular dysgenesis in contralateral biopsies from 218 patients with testicular germ cell cancer. J Pathol 2003, 200:370-374.
33. Chemes HE, Muzulin PM, Venara MC, Mulhmann Mdel C, Martinez M, Gamboni M Early manifestations of testicular dysgenesis in children: pathological phenotypes, karyotype correlations and precursor stages of tumor development. APMIS 2003, 111:12-24.
34. Cameron FJ, Sinclair AH Mutations in SRY and SOX9: Testis determining genes. Hum Mut 1997, 9:388-395.
35. Gimelli G, Gimelli S, Dimasi N, et al. Identification and molecular modelling of a novel familial mutation in the SRY gene implicated in pure gonadal dysgenesis. Eur J Hum Genet 2007, 15:76-80.
36. Achermann JC, Ozisik G, Ito M, et al. Gonadal determination and adrenal development are regulated by the orphan nuclear receptor steroidogenic factor-1, in a dose-dependent manner. J Clin Endocrinol Metab 2002, 87:1829-1833.
37. Lin L, Philbert P, Ferraz-de-Souza B, et al. Heterozygous missense mutations in steroidogenic factor 1 (SF1/Ad4BP, NR5A1) are associated with 46,XY disorders of sex development with normal adrenal function. J Clin Endocrinol Metab 2007, 92:991-999.
38. Chang HJ, Clark RD, Bachman H The phenotype of 45,X/46,XY mosaicism: An analysis of 92 prenatally diagnosed cases. Am J Hum Genet 1990, 45:156-167.
39. Alvarez-Nava F, Soto M, Borjas L, et al. Molecular analysis of SRY gene in patients with mixed gonadal dysgenesis. Ann Genet 2001, 44:155-159.
40. Verkauskas G, Jambert F, Lortat-Jacob S, Malan V, Thibaud E, Nihoul-Fékété C The long-term follow up of 33 cases of true hermaphroditism: A 40-year experience with conservative gonadal surgery. J Urol 2007, 177:726-731.
41. Maier EM, Leitner C, Löhrs U, Kuhnle U True hermaphroditism in an XY individual due to a familial point mutation of the SRY gene. J Pediatr Endocrinol Metab 2003, 16:575-580.
42. Talerman A, Verp MS, Senekjian E, Gilewski T, Vogelzang N True hermaphrodite with bilateral ovotestes, bilateral gonadoblastomas and dysgerminomas, 46,XX/46,XY karyotype, and a successful pregnancy. Cancer 1990, 66:2668-2672.
43. Williamson HO, Phansey SA, Mathur RS True hermaphroditism with term vaginal delivery and a review. Am J Obstet Gynecol 1981, 141:262-265.
44. Krob G, Braun A, Kuhnle U True hermaphroditism: geographical distribution, clinical findings, chromosomes and gonadal histology. J Obstet Gynaecol 2005, 25:401-403.
45. Krone N, Dhir V, Ivison HE, Arlt W Congenital adrenal hyperplasia and P450 oxidoreductase deficiency. Clin Endocrinol 2007, 66:162-172.
46. Arlt W, Walker EA, Draper N, et al. Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: Analytical study. Lancet 2004, 363:2128-2135.
47. Flück CE, Miller WL P450 oxidoreductase deficiency: A new form of congenital adrenal hyperplasia. Curr Opin Pediatr 2006, 18:435-441.
48. Ascoli M, Fanelli F, Segaloff DL The lutropin/choriogonadotropin receptor: A 2002 perspective. Endocr Rev 2002, 23:141-174.
49. Huhtaniemi I, Alevizaki M Gonadotrophin resistance. Best Prac Res Clin Endocrinol Metab 2006, 20:561-576.
50. Piersma D, Verhoef-Post M, Berns EM, Themmen APN LH receptor gene mutations and polymorphisms: An overview. Mol Cell Endocrinol 2007, 260-262:282-286.
51. Andersson S, Geissler WM, Wu L, et al. Molecular genetics and pathophysiology of 17 beta-hydroxysteroid dehydrogenase 3 deficiency. J Clin Endocrinol Metab 1996, 81:130-136.
52. Boehmer AL, Brinkmann AO, Sandkuijl LA, et al. 17 beta-hydroxysteroid dehydrogenase-3 deficiency: diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations. J Clin Endocrinol Metab 1999, 84:4713-4721.
53. Lee YS, Kirk JM, Stanhope RG, et al. Phenotypic variability in 17beta-hydroxysteroid dehydrogenase-3 deficiency and diagnostic pitfalls. Clin Endocrinol 2007, 67:20-28.
54. Qiu W, Zhou M, Labrie F, Lin SX Crystal structures of the multispecific 17beta-hydroxysteroid dehydrogenase type 5: Critical androgen regulation in human peripheral tissues. Mol Endocrinol 2004, 18:1798-1807.
55. Rösler A, Silverstein S, Abeliovich D A (R80Q) mutation in 17 beta-hydroxysteroid dehydrogenase type 3 gene among Arabs of Israel is associated with pseudohermaphroditism in males and normal asymptomatic females. J Clin Endocrinol Metab 1996, 81:1827-1831.
56. Imperato-McGinley J, Guerrero L, Gautier T, Peterson RE Steroid 5alpha-reductase deficiency in man: An inherited form of male pseudohermaphroditism. Science 1974, 186:1213-1215.
57. Wilson JD, Griffin JE, Russell DW Steroid 5α-reductase 2 deficiency. Endocr Rev 1993, 14:577-593.
58. Katz MD, Kligman I, Cai LQ, et al. Paternity by intrauterine insemination with sperm from a man with 5α-reductase-2 deficiency. N Eng J Med 1997, 336:994-997.
59. Nordenskjöld A, Ivarsson SA Molecular characterization of 5 alpha-reductase type 2 deficiency and fertility in a Swedish family. J Clin Endocrinol Metab 1998, 83:3236-3238.
60. Katz MD, Cai LQ, Zhu YS, et al. The biochemical and phenotypic characterization of females homozygous for 5 alpha-reductase 2 deficiency. J Clin Endocrinol Metab 1995, 80:3160-3167.
61. Quigley C, De Bellis A, Marschke KB, et al. Androgen receptor defects: Historical, clinical and molecular perspectives. Endocr Rev 1995, 16:271-321.
62. Ahmed SF, Cheng A, Dovey L, et al. Phenotypic features, androgen receptor binding, and mutational analysis in 278 clinical cases reported as androgen insensitivity syndrome. J Clin Endocrinol Metab 2000, 85:658-665.
63. Jenster G, van der Korput JA, Trapman J, Brinkmann AO Functional domains of the human androgen receptor. J Steroid Biochem Mol Biol 1992, 41:671-675.
64. Heinlein CA, Chang C Androgen receptor (AR) coregulators: An overview. Endocr Rev 2002, 23:175-200.
65. Tut TG, Ghadessy FJ, Trifiro MA, Pinsky L, Yong EL Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility. J Clin Endocrinol Metab 1997, 82:3777-3782.
66. Cheung-Flynn J, Prapapanich V, Cox MB, Riggs DL, Suarez-Quian C, Smith DF Physiological role for the cochaperone FKBP52 in androgen receptor signalling. Mol Endocrinol 2005, 19:1654-1666.
67. Bangsbøll S, Qvist I, Lebech PE, Lewinsky M Testicular feminization syndrome and associated gonadal tumors in Denmark. Acta Obstet Gynecol Scand 1992, 71:63-66.
68. Boehmer AL, Brinkmann AO, Brüggenwirth H, et al. Genotype versus phenotype in families with androgen insensitivity syndrome. J Clin Endocrinol Metab 2001, 86:4151-4160.
69. Hannema SE, Scott IS, Hodapp J, et al. Residual activity of mutant androgen receptors explains Wolffian duct development in the complete androgen insensitivity syndrome. J Clin Endocrinol Metab 2004, 89:5815-5822.
70. Deeb A, Hughes IA Inguinal hernia in female infants: A cue to check the sex chromosomes?. BJU Int 2005, 96:401-403.
71. Yong EL, Loy CJ, Sim KS Androgen receptor gene and male infertility. Hum Reprod Update 2003, 9:1-7.
72. Ong YC, Wong HB, Adaikan G, Yong EL Directed pharmacological therapy of ambiguous genitalia due to an androgen receptor gene mutation. Lancet 1999, 354:1444-1445.
73. Sinnecker GH, Hiort O, Nitsche EM, Holterhus PM, Kruse K Functional assessment and clinical classification of androgen sensitivity in patients with mutations of the androgen receptor gene: German Collaborative Intersex Study Group. Eur J Pediatr 1997, 156:7-14.
74. Nagy L, Schwabe JW Mechanism of the nuclear receptor molecular switch. Trends Biochem Sci 2004, 29:317-324.
75. Radmayr C, Culig Z, Glatzl J, Neuschmid-Kaspar F, Bartsch G, Klocker H Androgen receptor point mutations as the underlying molecular defect in 2 patients with androgen insensitivity syndrome. J Urol 1997, 158:1553-1556.
76. Deeb A, Mason C, Lee YS, Hughes IA Correlation between genotype, phenotype and sex of rearing in 111 patients with partial androgen insensitivity syndrome. Clin Endocrinol 2005, 63:56-62.
77. Köhler B, Lumbroso S, Leger J, et al. Androgen insensitivity syndrome: Somatic mosaicism of the androgen receptor in seven families and consequences for sex assignment and genetic counselling. J Clin Endocrinol Metab 2005, 90:106-111.
78. Boehmer AL, Brinkmann AO, Nijman RM, et al. Phenotypic variation in a family with partial androgen insensitivity syndrome explained by differences in 5alpha dihydrotestosterone availability. J Clin Endocrinol Metab 2001, 86:1240-1246.
79. Holterhus PM, Werner R, Hoppe U, et al. Molecular features and clinical phenotypes in androgen insensitivity syndrome in the absence and presence of androgen receptor gene mutations. J Mol Med 2005, 83:1005-1113.
80. Lonard DM, O'Malley BW Nuclear receptor coregulators and human disease. Endocr Rev 2007, 28:575-587.
81. Mongan NP, Lim HN, Hughes IA Genetic evidence to exclude the androgen receptor-polyglutamine associated coactivator, ARA-24, as a cause of male undermasculinisation. Eur J Endocrinol 2001, 145:809-811.
82. Lim HN, Hawkins JR, Hughes IA Genetic evidence to exclude the androgen receptor co-factor, ARA70 (NCOA4) as a candidate gene for the causation of undermasculinised genitalia. Clin Genet 2001, 59:284-286.
83. Xu J, Liao L, Ning G, Yoshida-Komiya H, Deng C, O'Malley BW The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development. Proc Natl Acad Sci USA 2000, 97:6379-6384.
84. Mongan NP, Jääskeläinen J, Bhattacharyya S, Leu RM, Hughes IA Steroid receptor coactivator-3 glutamine repeat polymorphism and the androgen insensitivity syndrome. Eur J Endocrinol 2003, 148:277-279.
85. Adachi M, Takayanagi R, Tomura A, et al. Androgen-insensitivity syndrome as a possible coactivator disease. N Eng J Med 2000, 343:856-862.
86. Hughes IA A novel explanation for resistance to androgens. N Engl J Med 2000, 343:881-882.
87. La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991, 352:77-79.
88. Lim HN, Chen H, McBride S, et al. Longer polyglutamine tracts in the androgen receptor are associated with moderate to severe undermasculinized genitalia in XY males. Hum Mol Genet 2000, 9:829-834.
89. Mengual L, Oriola J, Ascaso C, Ballesca JL, Oliva R An increased CAG repeat length in the androgen receptor gene in azoospermic ICSI candidates. J Androl 2003, 24:279-284.
90. Zinn AR, Ramos P, Elder FF, Kowal K, Samango-Sprouse C, Ross JL Androgen receptor CAGn repeat length influences phenotype of 47,XXY (Klinefelter) syndrome. J Clin Endocrinol Metab 2005, 90:5041-5046.
91. Tsujimoto Y, Takakuwa T, Takayama H, et al. In situ shortening of CAG repeat length within the androgen receptor gene in prostatic cancer and its possible precursors. Prostate 2004, 58:283-290.
92. Zitzmann M, Nieschlag E The CAG repeat polymorphism within the androgen receptor gene and maleness. Int J Androl 2003, 26:76-83.
93. Ibanez L, Ong KK, Mongan N, et al. Androgen receptor gene CAG repeat polymorphism in the development of ovarian hyperandrogenism. J Clin Endocrinol Metab 2003, 88:3333-3338.
94. Aschim EL, Nordenskjold A, Giwercman A, et al. Linkage between cryptorchidism, hypospadias, and GGN repeat length in the androgen receptor gene. J Clin Endocrinol Metab 2004, 89:5105-5109.
95. Werner R, Holterhus PM, Binder G, et al. The A645D mutation in the hinge region of the human androgen receptor (AR) gene modulates AR activity, depending on the context of the polymorphic glutamine and glycine repeats. J Clin Endocrinol Metab 2006, 91:3515-3520.
96. Visser JA AMH signaling: from receptor to target gene. Mol Cell Endocrinol 2003, 211:65-73.
97. Josso N, Belville C, di Clemente N, Picard JY AMH and AMH receptor defects in persistent Müllerian duct syndrome. Hum Reprod Update 2005, 11:351-356.
98. Imbeaud S, Carré-Eusèbe D, Rey R, Belville C, Josso N, Picard JY Molecular genetics of the persistent Müllerian duct syndrome: A study of 19 families. Hum Mol Genet 1994, 3:125-131.
99. Imbeaud S, Faure E, Lamarre I, et al. Insensitivity to antiMüllerian hormone due to a mutation in the human antiMüllerian hormone receptor. Nat Genet 1995, 11:382-388.
100. Zenaty D, Dijoud F, Morel Y, et al. Bilateral anorchia in infancy: Occurrence of micropenis and the effect of testosterone treatment. J Pediatr 2006, 149:687-691.
101. Philibert P, Zenaty D, Lin L, et al. Mutational analysis of steroidogenic factor 1 (NR5a1) in 24 boys with bilateral anorchia: A French collaborative study. Hum Reprod 2007, 22:3255-3261.
102. Law H, Mushtaq I, Wingrove K, Malone M, Sebire NJ Histopathological features of testicular regression syndrome: Relation to patient age and implications for management. Fetal Pediatr Pathol 2006, 25:119-129.
103. Emir H, Ayik B, Eliçevik M, et al. Histological evaluation of the testicular nubbins in patients with nonpalpable testis: Assessment of etiology and surgical approach. Pediatr Surg Int 2007, 23:41-44.
104. McEachern R, Houle AM, Garel L, Van Vliet G Lost and found testes: The importance of the hCG stimulation test and other testicular markers to confirm a surgical declaration of anorchia. Horm Res 2004, 62:124-128.
105. Lee MM, Donahoe PK, Silverman BL, et al. Measurements of serum Müllerian inhibiting substance in the evaluation of children with nonpalpable gonads. N Engl J Med 1997, 336:1480-1486.
106. Boisen KA, Chellakooty M, Schmidt IM, et al. Hypospadias in a cohort of 1072 Danish newborn boys: Prevalence and relationship to placental weight, anthropometrical measurements at birth, and reproductive hormone levels at three months of age. J Clin Endocrinol Metab 2005, 90:4041-4046.
107. Gorlov IP, Kamat A, Bogatcheva NV, et al. Mutations of the GREAT gene cause cryptorchidism. Hum Molec Genet 2002, 11:2309-2318.
108. Ferlin A, Simonato M, Bartoloni L, et al. The INSL3-LGR8/GREAT ligand-receptor pair in human cryptorchidism. J Clin Endocrinol Metab 2003, 88:4273-4279.
109. Yamazawa K, Wada Y, Sasagawa I, Aoki K, Ueoka K, Ogata T Mutation and polymorphism analyses of INSL3 and LGR8/GREAT in 62 Japanese patients with cryptorchidism. Horm Res 2006, 67:73-76.
110. Damgaard IN, Skakkebaek NE, Toppari J, et al. Persistent pesticides in human breast milk and cryptorchidism. Environ Health Perspect 2006, 114:1133-1138.
111. John Radcliffe Hospital Cryptorchidism Study Group Cryptorchidism: A prospective study of 7500 consecutive male births, 1984-1988. Arch Dis Child 1992, 67:892-899.
112. Buemann B, Henriksen H, Villumsen AL, Westh A, Zachau-Christiansen B Incidence of undescended testes in the newborn. Acta Chir Scand 1961, 283:289-293.
113. Boisen KA, Kaleva M, Main KM, et al. Difference in prevalence of congenital cryptorchidism in infants between two Nordic countries. Lancet 2000, 363:1264-1269.
114. Abdullah NA, Pearce MS, Parker L, Wilkinson JR, McNally RJQ Evidence of an environmental contribution to the aetiology of cryptorchidism and hypospadias?. Eur J Endocrinol 2007, 22:615-620.
115. Sharpe R Hormones and testis development and the possible adverse effects of environmental chemicals. Toxicol Lett 2001, 120:221-232.
116. Jorgensen N, Asklund G, Carlsen E, Skakkebaek NE Coordinated European investigations of semen quality: Results from studies of Scandinavian young men is a matter of concern. Int J Androl 2006, 29:54-61.
117. Skakkebaek NE, Rajpert-De Meyts E, Jorgensen N, et al. Testicular cancer trends as "whistle blowers" of testicular developmental problems in populations. Int J Androl 2007, 30:198-204.
118. Bay K, Asklund C, Skakkebaek NE, Andersson AM Testicular dysgenesis syndrome: possible role of endocrine disruptors. Best Pract Res Clin Endocrinol Metab 2006, 20:77-90.
119. Acerini CL, Hughes IA Endocrine disrupting chemicals: A new and emerging public health problem?. Arch Dis Child 2006, 91:633-641.
120. Swan SH Intrauterine exposure to diethylstilbestrol: Long-term effects in humans. APMIS 2000, 108:793-804.
121. Weidner IS, Møller H, Jensen TK, Skakkebaek NE Cryptorchidism and hypospadias in sons of gardeners and farmers. Environ Health Perspect 1998, 106:793-796.
122. Ema M, Myawaki E, Hirose A, Kamata E Decreased anogenital distance and increased incidence of undescended testes in fetuses of rats given monobenzyl phthalate, a major metabolite of butyl benzyl phthalate. Reprod Toxicol 2003, 17:407-412.
123. Swan SH, Main KM, Liu F, et al. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Perspect 2005, 113:1056-1061.
124. Baskin LS, Ebbers MB Hypospadias: Anatomy, etiology, and technique. J Ped Surg 2006, 41:463-472.
125. Rey RA, Codner E, Iniguez G, et al. Low risk of impaired testicular Sertoli and Leydig cell functions in boys with isolated hypospadias. J Clin Endocrinol Metab 2005, 90:6035-6040.
126. Holmes NM, Miller WL, Baskin LS Lack of defects in androgen production in children with hypospadias. J Clin Endocrinol Metab 2004, 89:2811-2816.
127. Fukami M, Wada Y, Miyabayashi K, et al. CXorf6 is a causative gene for hypospadias. Nat Genet 2006, 38:1369-1371.
128. Chen T, Li Q, Xu J, et al. Mutation screening of BMP4, BMP7, HOXA4 and HOXB6 genes in Chinese patients with hypospadias. Eur J Hum Genet 2007, 15:23-28.
129. Goodman FR, Bacchelli C, Brady AF, et al. Novel HOXA13 mutations and the phenotypic spectrum of hand-foot-genital syndrome. Am J Hum Genet 2000, 67:197-202.
130. Fredell L, Kockum I, Hansson E, et al. Heredity of hypospadias and the significance of low birth weight. J Urol 2002, 167:1423-1427.
131. Brouwers MM, Feitz WF, Roelofs LA, Kiemeney LA, de Gier RP, Roeleveld N Risk factors for hypospadias. Eur J Pediatr 2007, 166:671-678.
132. Li J, Willingham E, Baskin LS Gene expression profiles in mouse urethral development. BJU Int 2006, 98:880-885.
133. Laguna MP, Pizzocaro G, Klepp O, et al. EAU guidelines on testicular cancer. Eur Urol 2001, 40:102-110.
134. Mostofi FK, Sobin LH Histological typing of testicular tumors: International histological classification of tumors 1977, World Health Organization, Geneva.
135. World Health Organization classification of tumors: Pathology and genetics of the urinary system and male genital organs 2004, IARC Press, [city]. J.N. Eble, G. Sauter, J.L. Epstein (Eds.).
136. Ulbright TM Germ cell tumors of the gonads: A selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues. Mod Pathol 2005, 18:S61-S79.
137. Cools M, Drop SLS, Wolffenbuttel KP, Oosterhuis JW, Looijenga LHJ Germ cell tumors in the intersex gonad: Old paths, new directions, moving frontiers. Endocr Rev 2006, 27:468-484.
138. Bahrami A, Ro JY, Ayala AG An overview of testicular germ cell tumors. Arch Pathol Lab Med 2007, 131:1267-1280.
139. Hannema SE, Hughes IA Neoplasia and intersex states. Clinical endocrine oncology 2008, Blackwell, Oxford (UK), (in press). Second edition. I.D. Hay, J.A.H. Wass (Eds.).
140. Rajpert-De Meyts E, Bartkova J, Sansom M, et al. The emerging phenotype of the testicular carcinoma in situ germ cell. APMIS 2003, 111:267-278.
141. Satgé D, Sascoe AJ, Cure H, Leduc B, Sommelet D, Vekemans MJ An excess of testicular germ cell tumors in Down's syndrome: Three case reports and a review of the literature. Cancer 2003, 80:929-935.
142. Moe-Behrens GHG, Klinger FG, Eskild W, Grotmol T, Haugen TB, De Felici M Akt/PTEN signaling mediates estrogen-dependent proliferation of primordial germ cells in vitro. Mol Endocrinol 2003, 17:2630-2638.
143. Pena-Alonso R, Nieto K, Alvarez R, et al. Distribution of Y-chromosome bearing cells inn gonadoblastoma and dysgenetic testis in 45,X,/46,XY infants. Mod Pathol 2005, 18:439-445.
144. Hoei-Hansen CE, Carlsen E, Jorgensen N, Leffers H, Skakkebaek NE, Rajpert-De Meyts E Towards a non-invasive method for early detection of testicular neoplasia in semen samples by identification of fetal germ cell-specific markers. Hum Reprod 2007, 22:167-173.
145. Lefevre H, Bouvattier C, Lahlou N, Adamsbaum C, Bougnères P, Carel JC Prepubertal gynaecomastia in Peutz-Jeghers syndrome: Incomplete penetrance in a familial case and management with an aromatase inhibitor. Eur J Endocrinol 2006, 154:221-227.
146. Brown B, Ram A, Clayton P, Humphrey G Conservative management of bilateral Sertoli cell tumors of the testicle in association with the Carney complex: A case report. J Pediatr Surg 2007, 42:E13-E15.
147. Toppari J, Kaipia A, Kalevo M, et al. Inhibin gene expression in a large cell calcifying Sertoli cell tumor and serum inhibin and activin levels. APMIS 1998, 106:101-112.
148. Al-Agha OM, Axiotis CA An in-depth look at Leydig cell tumor of the testis. Arch Pathol Lab Med 2007, 131:311-317.
149. Jain M, Aiyer HM, Bajaj P, Dhar S Intracytoplasmic and intranuclear Reinke's crystals in a testicular Leydig-cell tumor diagnosed by fine-needle aspiration cytology: A case report with review of the literature. Diagn Cytopathol 2001, 25:162-164.
150. Val P, Jeays-Ward K, Swain A Identification of a novel population of adrenal-like cells in the mammalian testis. Dev Biol 2006, 299:250-256.
151. Stikkelbroek NM, Otten BJ, Pasic A, et al. High prevalence of testicular adrenal rest tumors, impaired spermatogenesis, and Leydig cell failure in adolescent and adult males with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2001, 86:5721-5728.
152. Seidenwurm D, Smathers RL, Kan P, Hoffman A Intratesticular adrenal rests diagnosed by ultrasound. Radiology 1985, 155:479-481.
153. Johnson RE, Scheithauer B Massive hyperplasia of testicular adrenal rests in a patient with Nelson's syndrome. Am J Clin Pathol 1982, 77:501-507.
154. Claahsen-van der Grinten HL, Sweep FC, Blickman JG, Hermus AR, Otten BJ Prevalence of testicular adrenal rest tumors in male children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Eur J Endocrinol 2007, 157:339-344.
155. Knudsen JL, Savage A, Mobb GE The testicular "tumor" of adrenogenital syndrome: A persistent diagnostic pitfall. Histopathology 1991, 19:468-470.
156. Claahsen-van der Grinten HL, Stikkelbroek NM, Sweep CG, Hermus AR, Otten BJ Fertility in patients with congenital adrenal hyperplasia. J Pediatr Endocrinol Metab 2006, 19:677-685.
157. Ogilvie CM, Crouch NS, Rumsby G, Creighton SM, Liao LM, Conway GS Congenital adrenal hyperplasia in adults: A review of medical, surgical and psychological issues. Clin Endocrinol 2006, 64:2-11.
158. Martinez-Aguayo A, Rocha A, Rojas N, et al. (2007). Testicular adrenal rest tumors and Leydig and Sertoli cell function in boys with classical congenital adrenal hyperplasia. J Clin Endocrinol Metab (E-pub ahead of print).
159. Claahsen-van der Grinten HL, Otten BJ, Sweep FC, Hermus AR Repeated successful induction of fertility after replacing hydrocortisone with dexamethasone in a patient with congenital adrenal hyperplasia and testicular adrenal rest tumors. Fertil Steril 2007, 88:705.e5-705.e8.
160. Claahsen-van der Grinten HL, Otten BJ, Takahashi S, et al. Testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia: Evaluation of pituitary-gonadal function before and after successful testis-sparing surgery in eight patients. J Clin Endocrinol Metab 2007, 92:612-615.
161. Penagarikano O, Mulle JG, Warren ST The pathophysiology of fragile X syndrome. Annu Rev Genomics Hum Genet 2007, 8:109-129.
162. Malter HE, Iber JG, Willemsen R, et al. Characterization of the full fragile X syndrome in fetal gametes. Nat Genet 1997, 15:165-169.
163. Butler MG, Brunschwig A, Miller LK, Hagerman RJ Standards for selected anthropometric measurements in males with the Fragile X syndrome. Pediatrics 1992, 89:1059-1062.
164. Carmi R, Meryash DL, Wood J, Gerald PS Fragile-X syndrome ascertained by the presence of macro-orchidism in a 5-month-old infant. Pediatrics 1984, 74:883-886.
165. Rudelli RD, Jenkins EC, Wisniewski K, Moretz R, Byrne J, Brown WT Testicular size in fetal fragile X syndrome. Lancet 1983, 1:1221-1222.
166. Johannisson R, Rehder H, Wendt V, Schwinger E Spermatogenesis in two patients with the fragile X syndrome: I. Histology: light and electron microscopy. Hum Genet 1987, 76:141-147.
167. Slegtenhorst-Eegdeman KE, De Rooij DG, Verhoef-Post M, et al. Macroorchidism in FMR1 knockout mice is caused by increased Sertoli cell proliferation during testicular development. Endocrinology 1998, 139:156-162.
168. Coutant R, Lumbroso S, Rey R, et al. Macroorchidism due to autonomous hyperfunction of Sertoli cells and Gsa gene mutation: An unusual expression of McCune-Albright syndrome in a prepubertal boy. J Clin Endocrinol Metab 2001, 86:1778-1881.
169. Arrigo T, Pirazzoli P, De Sanctis L, et al. McCune-Albright syndrome in a boy may present with a monolateral macroorchidism as an early and isolated clinical manifestation. Horm Res 2006, 65:114-119.
170. Spiegel AM, Weinstein LS Inherited diseases involving G proteins and G protein coupled receptors. Annu Rev Med 2004, 55:27-39.
171. Rey RA, Venara M, Coutant R, et al. Unexpected mosaicism of R201H-GNAS1 mutant-bearing cells in the testis underlie macro-orchidism without sexual precocity in McCune-Albright syndrome. Hum Mol Genet 2006, 15:3538-3543.
172. Velaga MR, Wright G, Crofton PM, et al. Macro-orchidism in two unrelated prepubertal boys with a normal FSH receptor. Horm Res 2005, 64:1-2.
173. Castro-Magana M, Angulo M, Canas A, Sharp A, Fuentes B Hypothalamic-pituitary gonadal axis in boys with primary hypothyroidism and macroorchidism. J Pediatr 1988, 112:397-402.
174. Jannini EA, Ulisse S, D'Armiento M Macroorchidism in juvenile hypothyroidism. J Clin Endocrinol Metab 1995, 80:2543-2544.
175. De Leener A, Montanelli L, Van Durme J, et al. Presence and absence of follicle-stimulating hormone receptor mutations provide some insights into spontaneous ovarian hyperstimulation syndrome physiopathology. J Clin Endocrinol Metab 2006, 91:555-562.
176. Suarez EA, d'Alva CB, Campbell A, et al. Absence of mutation in the follicle-stimulating hormone receptor gene in severe primary hypothyroidism associated with gonadal hyperstimulation. J Pediatr Endocrinol Metab 2007, 20:923-931.
177. Parent AS, Teilmann G, Juul A, Skakkebaek NE, Toppari J, Bourguignon JP The timing of normal puberty and the age limits of sexual precocity: Variations around the world, secular trends, and changes after migration. Endocr Rev 2003, 24:668-693.
178. Boas M, Boisen KA, Virtanen HE, et al. Postnatal penile length and growth rate correlate to serum testosterone levels: A longitudinal study of 1962 normal boys. Eur J Endocrinol 2006, 154:125-129.
179. Andersson AM, Toppari J, Haavisto AM, et al. Longitudinal reproductive hormone profiles in infants: Peak of inhibin B levels in infant boys exceeds levels in adult men. J Clin Endocrinol Metab 1998, 83:675-681.
180. Sharpe RM, McKinnell C, Kivlin G, Fisher JS Proliferation and functional maturation of Sertoli cells, and their relevance to disorders of testis function in adulthood. Reproduction 2003, 125:769-784.
181. Main KM, Toppari J, Suomi AM, et al. Larger testes and higher inhibin B levels in Finnish than in Danish newborn boys. J Clin Endocrinol Metab 2006, 91:2732-2737.
182. Suomi AM, Main KM, Kaleva M, et al. Hormonal changes in 3-month old cryptorchid boys. J Clin Endocrinol Metab 2006, 91:953-958.
183. Conte FA, Grumbach MM, Kaplan SL A diphasic pattern of gonadotropin secretion in patients with the syndrome of gonadal dysgenesis. J Clin Endocrinol Metab 1975, 4:670-674.
184. Plant TM The male monkey as a model for the study of the neurobiology of puberty onset in man. Mol Cell Endocrinol 2006, 254/255:97-102.
185. Acerini CL, Tasker RC (2007). Traumatic brain injury induced hypothalamic-pituitary dysfunction: A paediatric perspective. Pituitary (E-pub ahead of print).
186. Darzy KH, Shalet SM Hypopituitarism as a consequence of brain tumors and radiotherapy. Pituitary 2005, 8:203-211.
187. Seminara SB Kisspeptin in reproduction. Semin Reprod Med 2007, 25:337-343.
188. Kauffman AS, Clifton DK, Steiner RA Emerging ideas about kisspeptin-GPR54 signalling in the neuroendocrine regulation of reproduction. Trends Neuroscience 2007, 30:504-511.
189. Seminara SG, Messager S, Chatzidaki EE, et al. The GPR54 gene as a regulator of puberty. N Engl J Med 2003, 349:1614-1627.
190. Semple RK, Achermann JC, Ellery J, et al. Two novel missense mutations in G protein-coupled receptor 54 in a patient with hypogonadotrophic hypogonadism. J Clin Endocrinol Metab 2005, 90:1849-1855.
191. Dhillo WS, Chaudhri OB, Patterson M, et al. Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males. J Clin Endocrinol Metab 2005, 90:6609-6615.
192. Shahab M, Mastronardi C, Seminara SB, Crowley WF, Ojeda SR, Plant TM Increased hypothalamic GPR54 signalling: A potential mechanism for initiation of puberty in primates. Proc Natl Acad Sci USA 2005, 102:2129-2134.
193. Kaplowitz PB Diagnostic value of testosterone therapy in boys with delayed puberty. Amer J Dis Child 1989, 143:116-120.
194. Kosugi S, Van Dop C, Geffner ME, et al. Characterisation of heterogeneous mutations causing constitutive activation of the luteinising hormone receptor in familial male precocious puberty. Hum Mol Genet 1995, 4:183-188.
195. Richter-Unruh A, Wessels HT, Menken U, et al. Male LH-independent sexual precocity in a 3.5-year old boy caused by a somatic activating mutation of the LH receptor in a Leydig cell tumor. J Clin Endocrinol Metab 2002, 87:1052-1056.
196. d'Alva CB, Brito VN, Palhares HMC, et al. A single somatic activating Asp578His mutation of the luteinising hormone receptor causes Leydig cell tumor in boys with gonadotrophin-independent precocious puberty. Clin Endocrinol 2006, 65:408-410.
197. Liu G, Duranteau L, Carel JC, Monroe J, Doyle DA, Shenker A Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinising hormone receptor. N Engl J Med 1999, 341:1731-1736.
198. Kreher NC, Pescovitz OH, Delameter P, Tiulpakov A, Hochberg Z Treatment of familial male-limited precocious puberty with bicalutamide and anastrozole. J Pediatr 2006, 149:416-420.
199. Weinstein LS, Liu J, Sakamoto A, Xie T, Chen M GNAS: Normal and abnormal functions. Endocrinology 2004, 145:5459-5464.
200. Wildt L, Marshall G, Knobil E Experimental induction of puberty in the infantile female rhesus monkey. Science 1980, 207:1373-1375.
201. Eugster EA, Clarke W, Kletter GB, et al. Efficacy and safety of histrelin subdermal implant in children with central precocious puberty: A multicenter trial. J Clin Endocrinol Metab 2007, 92:1697-1704.
202. Ravio T, Falardeau J, Dwyer A, et al. Reversal of idiopathic hypogonadotropic hypogonadism. N Engl J Med 2007, 357:863-873.
203. Farooqi S, O'Rahilly S Genetics of obesity in humans. Endocr Rev 2006, 27:710-718.
204. Farooqi IS, Wangensteen T, Collins S, et al. Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. N Engl J Med 2007, 356:237-247.
205. Farooqi IS, Matarese G, Lord GM, et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 2002, 110:1093-1103.
206. Richmond EJ, Rogol AD Male pubertal development and the role of androgen therapy. Nat Clin Pract Endocrinol Metab 2007, 3:338-344.
207. Nieschlag E Testosterone treatment comes of age: New options for hypogonadal men. Clin Endocrinol 2006, 65:275-281.
208. Swerdloff RS, Wang C, Cunningham G, et al. Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men. J Clin Endocrinol Metab 2000, 85:4500-4510.
209. Mazer N, Bell D, Wu J, et al. Comparison of the steady-state pharmacokinetics, metabolism, and variability of a transdermal testosterone patch versus a transdermal testosterone gel in hypogonadal men. J Sex Med 2005, 2:213-226.
210. Ogilvy-Stuart AL, Brian CE Early assessment of ambiguous genitalia. Arch Dis Child 2004, 89:401-407.
211. Ranke MB Diagnostic of endocrine function in children and adolescents 2003, Karger, Basel. Second edition.
212. Hochberg Z Practical algorithms in pediatric endocrinology 2007, Karger, Basel. Second edition.
213. Ng KL, Ahmed SF, Hughes IA Pituitary-gonadal axis in male undermasculinisation. Arch Dis Child 2000, 82:54-58.
214. Dixon J, Wallace AM, O'Toole S, Ahmed SF (2007). Prolonged human chorionic gonadotrophin stimulation as a tool for investigating and managing undescended testes. Clin Endocrinol (E-pub ahead of print).
215. Tomlinson C, Macintyre H, Dorrian CA, Ahmed SF, Wallace AM Testosterone measurements in early infancy. Arch Dis Child Fetal Neonatal Ed 2004, 89:F558-F559.
216. Rey RA, Belville C, Nihoul-Fékété C, et al. Evaluation of gonadal function in 107 intersex patients by means of serum antimüllerian hormone measurement. J Clin Endocrinol Metab 1999, 84:627-631.
217. Lee MM, Misra M, Donohoe PK, MacLaughlin DT MIS/AMH in the assessment of cryptorchidism and intersex conditions. Mol Cell Endocrinol 2003, 211:91-98.
218. Josso N, Picard JY, Rey R, di Clemente N Testicular anti-Mullerian hormone: History, genetics, regulation and clinical applications. Pediatr Endocrinol Rev 2006, 3:347-358.
219. Bergadá I, Milani C, Bedecarrás P, et al. Time course of the serum gonadotrophin surge, inhibins, and anti-Mullerian hormone in normal newborn males during the first month of life. J Clin Endocrinol Metab 2006, 91:4092-4098.
220. Philibert P, Zenaty D, Lin L, et al. (2007). Mutational analysis of steroidogenic factor 1 (NR5a1) in 24 boys with bilateral anorchia: A French collaborative study. Hum Reprod (E-pub ahead of print).
221. Pearl MS, Hill MC Ultrasound of the scrotum. Semin Ultrasound CT MR 2007, 28:225-248.
222. Costabile RA How worrisome is testicular microlithiasis?. Curr Opinion Urol 2007, 17:419-423.
223. Greenfield DM, Walters SJ, Coleman RE, et al. Prevalence and consequences of androgen deficiency in young male cancer survivors in a controlled cross-sectional study. J Clin Endocrinol Metab 2007, 92:3476-3482.
224. Müller J, Sønksen J, Sommer P, et al. Cryopreservation of semen from pubertal boys with cancer. Med Pediatr Oncol 2000, 34:191-194.
225. Radicioni AF, Anzuini A, De Marco E, Nofroni I, Castracane VD, Lenzi A Change in serum inhibin B during normal male puberty. Eur J Endocrinol 2005, 152:403-409.
226. Nielsen CT, Skakkebaek NE, Richardson DW, et al. Onset of the release of spermatozoa (spermarche) in boys in relation to age, testicular growth, pubic hair, and height. J Clin Endocrinol Metab 1986, 62:532-535.
227. Pedersen JL, Nysom K, Jørgensen M, et al. Spermaturia and puberty. Arch Dis Child 1993, 69:384-387.
228. Mol NM, Sørensen N, Weihe P, et al. Spermaturia and serum hormone concentrations at the age of puberty in boys prenatally exposed to polychlorinated biphenyls. Eur J Endocrinol 2002, 146:357-363.
229. Layman LC Hypogonadotropic hypogonadism. Endocrinol Metab Clin N Am 2007, 36:283-296.
230. Trarbach EB, Silveira LG, Latronio AC (2007). Genetic insights into human isolated gonadotropin deficiency. Pituitary (E-pub ahead of print).
231. Burman P, Ritzen EM, Lindgren AC Endocine dysfunction in Prader-Willi syndrome: A review with special reference to GH. Endocr Rev 2001, 22:787-799.
232. Blaque OE, Leroux MR Bardet-Biedl syndrome: An emerging pathomechanism of intracellular transport. Cell Mol Life Sci 2006, 63:2145-2161.
233. Bhagavath B, Layman LC The genetics of hypogonadotropic hypogonadism. Semin Reprod Med 2007, 25:272-286.
234. Lanfranco F, Kamischke A, Zitzmann M Klinefelter's syndrome. Lancet 2004, 364:273-283.
235. Allanson JE Noonan syndrome. Am J Genet C Semin Med Genet 2007, 145:274-279.
236. Melo KF, Martin RM, Costa EM, et al. An unusual phenotype of Frasier syndrome due to IVS9 14C.T mutation in the WT1 gene: Predominantly male ambiguous genitalla and absence of gonadal dysgenesis. J Clin Endocrinol Metab 2002, 87:2500-2505.
237. Rutter MM, Rose SR Long-term endocrine sequelae of childhood cancer. Curr Opin Pediatr 2007, 19:480-487.